jsc2022e083017

A preflight image of a BioCell developed by BioServe Space Technologies that contains 162 beating cardiac spheroids derived from induced pluripotent stem cells (iPSCs). These cells will be incubated and put under the microscope in space as part of the Cardinal Heart 2.0 investigation. Image courtesy of Drs. Joseph Wu, Dilip Thomas and Xu Cao, Stanford Cardiovascular Institute.

jsc2022e083017 (4/23/2022) --- A preflight image of a BioCell developed by BioServe Space Technologies that contains 162 beating cardiac spheroids derived from induced pluripotent stem cells (iPSCs). These cells are incubated and put under the microscope in space as part of the Effect of Microgravity on Drug Responses Using Heart Organoids (Cardinal Heart 2.0) investigation. Image courtesy of Drs. Joseph Wu, Dilip Thomas and Xu Cao, Stanford Cardiovascular Institute.

Album SpaceX_CRS-27_Science